go away stolwk, page-9

re: rick3 There was an ASX announcement when the shares were around 60 cents. It used the terms "breakthrough" and "FDA fast track approval". I initially read it in the Australian around 2 years ago.

I bought shares in 90 cent to 150 cent range after this announcement on the rise and sold out about 350 cents when the price appeared to stall.

There was no release of any supporting documentation to the market other than than the ASX release that I ever saw.

The reason I was given for CMQ not progressing the FDA issue was that CMQ had to use product from the actual manufacturing plant for FDA testing.